Aabid Shariff

This inventor holds 1 USPTO granted patent. Top assignee: Monsanto Technology LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aabid Shariff. Retrieved from https://idiyas.com/inventor/aabid-shariff-2d26el93

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aabid Shariff: Innovator in Plant Gene Expression

Introduction

Aabid Shariff is a notable inventor recognized for his contributions to the field of plant biotechnology. He has developed innovative methods and compositions that enhance gene expression in plants. His work is pivotal in advancing agricultural practices and improving crop yields.

Latest Patents

Aabid Shariff holds a patent titled "Methods and Compositions for Gene Expression in Plants." This patent represents a significant advancement in the ability to manipulate plant genetics for better performance and resilience.

Career Highlights

Shariff is currently employed at Monsanto Technology LLC, a leading company in agricultural biotechnology. His role involves research and development aimed at creating sustainable solutions for modern agriculture.

Collaborations

Throughout his career, Aabid has collaborated with esteemed colleagues, including Clayton T. Larue and Joel E. Ream. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Aabid Shariff's work in plant gene expression exemplifies the impact of innovative thinking in agriculture. His contributions are vital for the future of food security and sustainable farming practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…